Building bridges between researchers and patient research partners: A report from the grappa 2014 annual meeting

Journal of Rheumatology

Volumn 42, Issue 6, 2015, Pages 1021-1026

  De Wit, Maarten ^a   Campbell, Willemina ^a,b   Orbai, Ana Maria ^c   Tillett, William ^d   Fitzgerald, Oliver ^e   Gladman, Dafna D ^f   Lindsay, Chris A ^g   McHugh, Neil J ^d   Mease, Philip J ^h   O'Sullivan, Denis ⁱ   Steinkoenig, Ingrid ^j   Windisch, Glenn ^k   Goel, Niti ^l  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TORONTO WESTERN HOSPITAL   (Canada)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d ROYAL NATIONAL HOSPITAL FOR RHEUMATIC DISEASES   (United Kingdom)

^e ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY HEALTH NETWORK   (Canada)

^h AMGEN INC   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j LERNER RESEARCH INSTITUTE   (United States)

^k NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^l DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

GRAPPA; PATIENT PARTICIPATION; PATIENT RESEARCH PARTNERS; RESEARCH; RHEUMATOLOGY

Indexed keywords

CONFERENCE PAPER; DECISION MAKING; HUMAN; MEDICAL EDUCATION; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT PARTICIPATION; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SOCIAL COMPETENCE; TREATMENT OUTCOME; UNITED STATES; WORKSHOP;

EID: 84940506315     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.150123     Document Type: Conference Paper

References (20)

1. Abma TA, Pittens CA, Visse M, Elberse JE, Broerse JE. Patient involvement in research programming and implementation: A responsive evaluation of the dialogue model for research agenda setting. Health Expect 2014; May 30 (E-pub ahead of print).
2. Domecq JP, Prutsky G, Elraiyah T, Wang Z, Nabhan M, Shippee N, et al. Patient engagement in research: a systematic review. BMC Health Serv Res 2014;14:89.
3. Staniszewska S, Haywood KL, Brett J, Tutton L. Patient and public involvement in patient-reported outcome measures: evolution not revolution. Patient 2012;5:79-87.
4. Tillett W, Adebajo A, Brooke M, Campbell W, Coates LC, FitzGerald O, et al. Patient involvement in outcome measures for psoriatic arthritis. Curr Rheumatol Rep 2014;16:418.
5. de Wit M, Campbell W, FitzGerald O, Gladman DD, Helliwell PS, James J, et al. Patient participation in psoriasis and psoriatic arthritis outcome research: a report from the GRAPPA 2013 annual meeting. J Rheumatol 2014;41:1206-11.
6. Tillett W, Eder L, Goel N, De Wit M, Gladman DD, Fitzgerald O, et al. Enhanced patient involvement and the need to revise the core set-report from the Psoriatic Arthritis working group at OMERACT 2014. J Rheumatol 2015;42: in press.
7. Levin AA, Gottlieb AB. The International Dermatology Outcome Measures Group: Update from the GRAPPA 2014 annual meeting. J Rheumatol 2015;42:1027-8.
8. Tillett W, Eder L, Goel N, de Wit M, Ogdie A, Orbai AM, et al. Review of the psoriatic arthritis working group at OMERACT 12: a report from the GRAPPA 2014 annual meeting. J Rheumatol 2015;42:1048-51.
9. Mease PJ, Park J, Garg A, Gladman DD, Helliwell P. Development of simple clinical criteria for the definition of inflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2014 annual meeting. J Rheumatol 2015;42:1041-3.
10. Coates LC, Kavanaugh A, Mease PJ, Ritchlin CR. GRAPPA treatment recommendations: an update from the GRAPPA 2014 annual meeting. J Rheumatol 2015;42:1052-5.
11. de Wit MP, Berlo SE, Aanerud GJ, Aletaha D, Bijlsma JW, Croucher L, et al. European League Against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis 2011;70:722-6.
12. Cheung PP, de Wit M, Bingham III CO, Kirwan JR, Leong A, March L, et al. Recommendations for the involvement of patient research partners in OMERACT working groups. A report from the OMERACT 2014 working group on patient research partners. J Rheumatol 2015;42: in press.
13. Staniszewska S, Brett J, Mockford C, Barber R. The GRIPP checklist: strengthening the quality of patient and public involvement reporting in research. Int J Technol Assess Health Care 2011;27:391-9.
14. Abma TA, Nierse CJ, Widdershoven GA. Patients as partners in responsive research: methodological notions for collaborations in mixed research teams. Qual Health Res 2009;19:401-15.
15. van der Goes MC, Jacobs JW, Boers M, Andrews T, Blom-Bakkers MA, Buttgereit F, et al. Patient and rheumatologist perspectives on glucocorticoids: an exercise to improve the implementation of the European League Against Rheumatism (EULAR) recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2010;69:1015-21.
16. Hewlett SA. Patients and clinicians have different perspectives on outcomes in arthritis. J Rheumatol 2003;30:877-9.
17. De Wit M, Abma T, Koelewijn-van Loon M, Collins S, Kirwan J. Involving patient research partners has a significant impact on outcomes research: a responsive evaluation of the international OMERACT conferences. BMJ Open 2013;3 pii:e002241.
18. De Wit M, Abma T, Koelewijn-van Loon M, Collins S, Kirwan J. Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences-lessons learnt from a decade of collaboration in OMERACT: a qualitative study. BMJ Open 2013;3:e003311.
19. Hawk ET, Habermann EB, Ford JG, Wenzel JA, Brahmer JR, Chen MS Jr, et al. Five National Cancer Institute-designated cancer centers' data collection on racial/ethnic minority participation in therapeutic trials: a current view and opportunities for improvement. Cancer 2014;120 Suppl 7:1113-21.
20. Boers M, Kirwan JR, Tugwell P, Beaton D, Bingham CO, III, Conaghan PG, et al. The OMERACT handbook. [Internet. Accessed February 24, 2015.] Available from: www.omeract.org/pdf/ OMERACT-Handbook.pdf